Plott Ronald Todd
Reporting owner on Forms 3, 4 and 5, CIK 1768337.
Plott Ronald Todd reported on 1 issuer in 2 filings, the latest a Form 4 filed 2026-09-30.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| Phio Pharmaceuticals Corp. CIK 1533040 | director | 2 | 2026-09-30 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| Phio Pharmaceuticals Corp. Common Stock, $.0001 par value | 2026-09-29 | P bought | +5,000 | $1.04 | 42,000 | Form 4 |
| Phio Pharmaceuticals Corp. Common Stock, $.0001 par value | 2026-09-28 | P bought | +5,000 | $1.03 | 37,000 | Form 4 |
| Phio Pharmaceuticals Corp. Common Stock, $.0001 par value | 2026-09-28 | A granted | +17,000 | $0 | 32,000 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001683168-26-007499 | Phio Pharmaceuticals Corp. | 2026-09-30 | ||
| Form 4 0001683168-26-007482 | Phio Pharmaceuticals Corp. | 2026-09-29 |